ArticleJournal of biochemistry2022

DA-Raf and the MEK inhibitor trametinib reverse skeletal myocyte differentiation inhibition or muscle atrophy caused by myostatin and GDF11 through the non-Smad Ras-ERK pathway.

Ryuichi Masuzawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.